Insiders / Kumar Neil / Activity
Activity — Kumar Neil
39 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Feb 19, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $1.34M | -19K -7.21% | 243,581 0.12% of shares | medium |
| Feb 10, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $1.02M | -14K -1.98% | 701,485 0.36% of shares | medium |
| Feb 10, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $1.01M | -14K -0.31% | 4,504,407 2.30% of shares | medium |
| Mar 12, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $981.8K | -14K -2.12% | 661,349 0.34% of shares | medium |
| Mar 12, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $950.7K | -14K -0.31% | 4,464,562 2.28% of shares | medium |
| Jan 8, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $851.8K | -12K -0.25% | 4,546,882 2.33% of shares | medium |
| Jan 8, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $848.0K | -12K -1.52% | 744,171 0.38% of shares | medium |
| Jan 9, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $827.0K | -11K -0.24% | 4,520,302 2.31% of shares | medium |
| Jan 9, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $816.4K | -11K -1.45% | 716,061 0.37% of shares | medium |
| Mar 13, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $713.4K | -10K -1.60% | 635,686 0.33% of shares | medium |
| Mar 13, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $700.3K | -10K -0.23% | 4,448,206 2.28% of shares | medium |
| Mar 13, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $675.6K | -10K -0.22% | 4,438,447 2.27% of shares | medium |
| Mar 13, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $662.4K | -10K -1.48% | 645,996 0.33% of shares | medium |
| Feb 19, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $614.7K | -9K -3.50% | 235,053 0.12% of shares | medium |
| Jan 8, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $605.1K | -8K -0.18% | 4,538,747 2.32% of shares | medium |
| Jan 8, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $601.3K | -8K -1.09% | 736,086 0.38% of shares | medium |
| Feb 11, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $555.7K | -8K -0.17% | 4,490,587 2.30% of shares | medium |
| Feb 11, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $551.8K | -8K -1.12% | 687,880 0.35% of shares | medium |
| Jan 9, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $533.6K | -7K -0.95% | 726,580 0.37% of shares | medium |
| Jan 9, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $464.3K | -6K -0.13% | 4,530,979 2.32% of shares | medium |
| Feb 10, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $430.8K | -6K -0.13% | 4,498,447 2.30% of shares | medium |
| Feb 10, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $419.2K | -6K -0.83% | 695,686 0.36% of shares | medium |
| Mar 12, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $402.9K | -6K -0.13% | 4,458,747 2.28% of shares | medium |
| Mar 12, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $371.8K | -5K -0.81% | 655,986 0.34% of shares | medium |
| Feb 11, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $325.7K | -4K -0.66% | 679,680 0.35% of shares | medium |
| Feb 11, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $319.9K | -4K -0.10% | 4,482,408 2.29% of shares | medium |
| Feb 11, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $292.6K | -4K -0.59% | 675,686 0.35% of shares | medium |
| Feb 11, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $290.1K | -4K -0.09% | 4,478,447 2.29% of shares | medium |
| Feb 11, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $269.8K | -4K -0.08% | 4,486,812 2.30% of shares | medium |
| Feb 11, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $265.5K | -4K -0.54% | 684,164 0.35% of shares | medium |
| Jan 9, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $162.9K | -2K -0.29% | 733,535 0.38% of shares | medium |
| Jan 9, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $144.9K | -2K -0.04% | 4,518,447 2.31% of shares | medium |
| Jan 9, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $105.9K | -1K -0.03% | 4,537,046 2.32% of shares | medium |
| Feb 19, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $43.8K | -602 -0.26% | 234,451 0.12% of shares | low |
| Jan 8, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $30.1K | -400 -0.05% | 735,686 0.38% of shares | low |
| Jan 9, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $29.3K | -375 -0.05% | 715,686 0.37% of shares | low |
| Jan 8, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $22.6K | -300 -0.01% | 4,538,447 2.32% of shares | low |
| Mar 12, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $21.0K | -300 -0.01% | 4,458,447 2.28% of shares | low |
| Mar 12, 2026 | Sell | BBIO BridgeBio Pharma, Inc. Common Stock | $21.0K | -300 -0.05% | 655,686 0.34% of shares | low |